HM Insurance Group Adds Senior Pharmacist to Bolster Risk Evaluation and Cost Containment Capabilities

November 9, 2017

HM Insurance Group (HM) is pleased to announce that Dr. Jamie Holowka has joined the company in the role of senior pharmacist, operations administration. Having seen a continued increase in specialty drug costs and their role in the rising claims trend, HM sought to add specialized pharmaceutical expertise to its claims and underwriting areas, working to better manage business challenges now and into the future.

In her new role, Holowka is responsible for assisting with risk evaluation and cost containment practices. She also will serve as a pharmacy liaison to HM’s external TPA partners.

“It makes a lot of sense to bring a pharmaceutical expert to the table,” Dom Palmieri, senior vice president, operations and strategic partnerships, said. “Pharmaceuticals play a significant role in escalating claim costs, and we are working hard to see what can be done to better control the situation.”

Holowka brings experience as consultant for a nationwide, self-funded health insurance captive and extensive expertise in quality, cost management, efficiency, research and education. She has a Bachelor of Science degree in Pharmacy and a Doctor of Pharmacy, both from Duquesne University.